128 related articles for article (PubMed ID: 19908304)
21. Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial.
Heuft HG; Moog R; Fischer EG; Zingsem J;
Transfusion; 2013 Jan; 53(1):211-20. PubMed ID: 22612302
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic apheresis: results from a single center in Turkey.
Yavasoglu I; Kadikoylu G; Akyol A; Bolaman Z
Transfus Apher Sci; 2007 Jun; 36(3):249-53. PubMed ID: 17556022
[TBL] [Abstract][Full Text] [Related]
23. Hemoglobin and platelet count effect on platelet yields in plateletpheresis.
Guerrero-Rivera S; Gutiérrez-Espíndola G; Talavera JO; Meillón-García LA; Pedraza-Echevarría M; Pizzuto-Chávez J
Arch Med Res; 2003; 34(2):120-3. PubMed ID: 12700007
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective.
Nomani L; Raina TR; Sidhu M
Transfus Apher Sci; 2013 Jun; 48(3):341-3. PubMed ID: 23643473
[TBL] [Abstract][Full Text] [Related]
26. A critical comparison of platelet preparation methods.
Vassallo RR; Murphy S
Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
[TBL] [Abstract][Full Text] [Related]
27. [Quality control in producing thrombocytapheresis preparations with minimal leukocyte contamination].
Riggert J; Humpe A; Simson G; Köhler M
Beitr Infusionsther Transfusionsmed; 1997; 34():89-94. PubMed ID: 9417356
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
29. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
Procházková R; Andrýs C; Hubácková L; Krejsek J
Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
[TBL] [Abstract][Full Text] [Related]
30. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
Zeiler T; Gritzka D; Karger R; Kretschmer V
Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a platelet apheresis technique for the preparation of leukocyte-reduced platelet concentrates.
Zingsem J; Glaser A; Weisbach V; Zimmermann R; Neidhardt B; van Waeg G; Eckstein R
Vox Sang; 1998; 74(3):189-92. PubMed ID: 9595647
[TBL] [Abstract][Full Text] [Related]
32. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
[TBL] [Abstract][Full Text] [Related]
33. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
34. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
[TBL] [Abstract][Full Text] [Related]
35. How to stabilize the level of ionized calcium and citrate during plateletpheresis.
Farrokhi P; Farahmand H; Bismuth A; Suarez C; Ducot B; Gillon MC; Debat P; Laskowski P; Pinon F
Vox Sang; 1998; 74(1):7-12. PubMed ID: 9481853
[TBL] [Abstract][Full Text] [Related]
36. Pre-apheresis donor platelet count: an important platelet yield predictor.
Saluja K; Thakral B; Sharma RR; Marwaha N
J Clin Apher; 2006 Dec; 21(4):274. PubMed ID: 16847940
[No Abstract] [Full Text] [Related]
37. The use of PEG-rhuMGDF in platelet apheresis.
Kuter DJ
Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
DAS SS; Chaudhary RK; Shukla JS
Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
[TBL] [Abstract][Full Text] [Related]
39. Automated platelet collection using the latest apheresis devices in an Indian setting.
Agarwal P; Verma A
Transfus Apher Sci; 2009 Oct; 41(2):135-8. PubMed ID: 19709930
[TBL] [Abstract][Full Text] [Related]
40. The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective.
Hirani R; Peberdy J; Mondy P
Transfus Apher Sci; 2018 Apr; 57(2):239-242. PubMed ID: 29530405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
